Treatment of sarcomas: thinking out-of-the-box

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Nature medicine·2025

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.

Oncoimmunology·2023

Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.

European journal of cancer (Oxford, England : 1990)·2023

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.

Journal for immunotherapy of cancer·2022

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.

Genome medicine·2021

Epidemiology and treatment outcomes of bone and soft tissue sarcoma in pediatric and adolescent and young adult patients in Japan: data from population-based National Cancer Registry 2016-2019.

Cancer investigation·2026

Variations of Blood Concentration Levels of Reactive Carbonyl Species Among Three Case-Control Studies of Breast and Colorectal Cancer.

Cancer investigation·2026

Psychosocial and Sociodemographic Factors Associated with Perceived Barriers to Physical Activity in Patients Receiving Chemotherapy.

Cancer investigation·2026

Clinical, Allied Health, and Research/Advocacy Professionals' Perspectives on Body Image and Support Needs for Young Adults with Cancer; A Qualitative Study.

Cancer investigation·2026

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Cancer investigation·2026

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Cancer investigation·2026

Immune checkpoint inhibitors plus chemotherapy for early-stage or locally -advanced triple-negative breast cancer: a systematic review and Bayesian network meta-analysis of randomized trials.

Frontiers in oncology·2026

Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study.

Frontiers in oncology·2026

Pathological characteristics of cervical lymph node metastases in papillary thyroid carcinoma compared with lung adenocarcinoma.

Frontiers in oncology·2026

Contrast clearance analysis in post-operative brain metastases resection cavities: case series and literature review.

Frontiers in oncology·2026

Embrace Pain-A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors.

Psycho-oncology·2026

Adding Treatment-Continuity Metrics to Opioid Toxicity Investigation: A Triangulation Hypothesis for Applied Toxicology.

Journal of applied toxicology : JAT·2026

Related Experiment Videos

Treatment of sarcomas: thinking out-of-the-box

Related Concept Videos

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.

Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.

Epidemiology and treatment outcomes of bone and soft tissue sarcoma in pediatric and adolescent and young adult patients in Japan: data from population-based National Cancer Registry 2016-2019.

Variations of Blood Concentration Levels of Reactive Carbonyl Species Among Three Case-Control Studies of Breast and Colorectal Cancer.

Psychosocial and Sociodemographic Factors Associated with Perceived Barriers to Physical Activity in Patients Receiving Chemotherapy.

Clinical, Allied Health, and Research/Advocacy Professionals' Perspectives on Body Image and Support Needs for Young Adults with Cancer; A Qualitative Study.

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Immune checkpoint inhibitors plus chemotherapy for early-stage or locally -advanced triple-negative breast cancer: a systematic review and Bayesian network meta-analysis of randomized trials.

Interim efficacy and preliminary survival outcomes of polatuzumab vedotin in combination for diffuse large B-cell lymphoma: a retrospective real-world study.

Pathological characteristics of cervical lymph node metastases in papillary thyroid carcinoma compared with lung adenocarcinoma.

Contrast clearance analysis in post-operative brain metastases resection cavities: case series and literature review.

Embrace Pain-A Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Painful Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors.

Adding Treatment-Continuity Metrics to Opioid Toxicity Investigation: A Triangulation Hypothesis for Applied Toxicology.

Related Experiment Videos

Treatment of sarcomas: thinking out-of-the-box

Related Concept Videos

Related Articles